214 related articles for article (PubMed ID: 28791519)
1. Adolescents with moyamoya disease: clinical features, surgical treatment and long-term outcomes.
Zhao M; Zhang D; Wang S; Zhang Y; Wang R; Deng X; Gao F; Zhao J
Acta Neurochir (Wien); 2017 Nov; 159(11):2071-2080. PubMed ID: 28791519
[TBL] [Abstract][Full Text] [Related]
2. Ischemic Stroke in Young Adults with Moyamoya Disease: Prognostic Factors for Stroke Recurrence and Functional Outcome after Revascularization.
Zhao M; Deng X; Gao F; Zhang D; Wang S; Zhang Y; Wang R; Zhao J
World Neurosurg; 2017 Jul; 103():161-167. PubMed ID: 28408257
[TBL] [Abstract][Full Text] [Related]
3. Clinical features, surgical treatment, and long-term outcome in pediatric patients with moyamoya disease in China.
Bao XY; Duan L; Yang WZ; Li DS; Sun WJ; Zhang ZS; Zong R; Han C
Cerebrovasc Dis; 2015; 39(2):75-81. PubMed ID: 25573764
[TBL] [Abstract][Full Text] [Related]
4. Direct Bypass Versus Indirect Bypass in Adult Moyamoya Angiopathy with Symptoms or Hemodynamic Instability: A Meta-analysis of Comparative Studies.
Kim H; Jang DK; Han YM; Sung JH; Park IS; Lee KS; Yang JH; Huh PW; Park YS; Kim DS; Han KD
World Neurosurg; 2016 Oct; 94():273-284. PubMed ID: 27423200
[TBL] [Abstract][Full Text] [Related]
5. Transient Ischemic Attack in Pediatric Patients With Moyamoya Disease: Clinical Features, Natural History, and Predictors of Stroke.
Zhao M; Zhang D; Wang S; Zhang Y; Wang R; Zhao J
Pediatr Neurol; 2017 Oct; 75():48-54. PubMed ID: 28778481
[TBL] [Abstract][Full Text] [Related]
6. Moyamoya syndrome associated with neurofibromatosis Type 1: perioperative and long-term outcome after surgical revascularization.
Koss M; Scott RM; Irons MB; Smith ER; Ullrich NJ
J Neurosurg Pediatr; 2013 Apr; 11(4):417-25. PubMed ID: 23373626
[TBL] [Abstract][Full Text] [Related]
7. Outcome of repeat revascularization surgery for moyamoya disease after an unsuccessful indirect revascularization. Clinical article.
Pandey P; Steinberg GK
J Neurosurg; 2011 Aug; 115(2):328-36. PubMed ID: 21529138
[TBL] [Abstract][Full Text] [Related]
8. Impact of posterior cerebral artery involvement on long-term clinical and social outcome of pediatric moyamoya disease.
Funaki T; Takahashi JC; Takagi Y; Yoshida K; Araki Y; Kikuchi T; Kataoka H; Iihara K; Miyamoto S
J Neurosurg Pediatr; 2013 Dec; 12(6):626-32. PubMed ID: 24138143
[TBL] [Abstract][Full Text] [Related]
9. Surgical Revascularization for Pediatric Patients with Sickle Cell Disease and Moyamoya Disease in the Prevention of Ischemic Strokes: A Single-Center Case Series and a Systematic Review.
Aguilar-Salinas P; Hayward K; Santos R; Agarwal V; Sauvageau E; Hanel RA; Aldana PR
World Neurosurg; 2019 Mar; 123():435-442.e8. PubMed ID: 30496928
[TBL] [Abstract][Full Text] [Related]
10. Unstable moyamoya disease: clinical features and impact on perioperative ischemic complications.
Funaki T; Takahashi JC; Takagi Y; Kikuchi T; Yoshida K; Mitsuhara T; Kataoka H; Okada T; Fushimi Y; Miyamoto S
J Neurosurg; 2015 Feb; 122(2):400-7. PubMed ID: 25423271
[TBL] [Abstract][Full Text] [Related]
11. Stroke prevention by direct revascularization for patients with adult-onset moyamoya disease presenting with ischemia.
Kim T; Oh CW; Kwon OK; Hwang G; Kim JE; Kang HS; Cho WS; Bang JS
J Neurosurg; 2016 Jun; 124(6):1788-93. PubMed ID: 26636391
[TBL] [Abstract][Full Text] [Related]
12. Moyamoya disease in China: its clinical features and outcomes.
Duan L; Bao XY; Yang WZ; Shi WC; Li DS; Zhang ZS; Zong R; Han C; Zhao F; Feng J
Stroke; 2012 Jan; 43(1):56-60. PubMed ID: 22020027
[TBL] [Abstract][Full Text] [Related]
13. Effectiveness of surgical revascularization for stroke prevention in pediatric patients with sickle cell disease and moyamoya syndrome.
Yang W; Xu R; Porras JL; Takemoto CM; Khalid S; Garzon-Muvdi T; Caplan JM; Colby GP; Coon AL; Tamargo RJ; Huang J; Ahn ES
J Neurosurg Pediatr; 2017 Sep; 20(3):232-238. PubMed ID: 28686127
[TBL] [Abstract][Full Text] [Related]
14. Posterior cerebral territory ischemia in pediatric moyamoya: Surgical techniques and long-term clinical and radiographic outcomes.
Montaser A; Kappel AD; Driscoll J; Day E; Karsten M; See AP; Orbach DB; Smith ER
Childs Nerv Syst; 2024 Mar; 40(3):791-800. PubMed ID: 37955716
[TBL] [Abstract][Full Text] [Related]
15. Down syndrome and moyamoya: clinical presentation and surgical management.
See AP; Ropper AE; Underberg DL; Robertson RL; Scott RM; Smith ER
J Neurosurg Pediatr; 2015 Jul; 16(1):58-63. PubMed ID: 25837890
[TBL] [Abstract][Full Text] [Related]
16. Clinical features and long-term outcomes of moyamoya disease: a single-center experience with 528 cases in China.
Liu XJ; Zhang D; Wang S; Zhao YL; Teo M; Wang R; Cao Y; Ye X; Kang S; Zhao JZ
J Neurosurg; 2015 Feb; 122(2):392-9. PubMed ID: 25423267
[TBL] [Abstract][Full Text] [Related]
17. Long-term follow-up of pediatric moyamoya disease treated by combined direct-indirect revascularization surgery: single institute experience with surgical and perioperative management.
Rashad S; Fujimura M; Niizuma K; Endo H; Tominaga T
Neurosurg Rev; 2016 Oct; 39(4):615-23. PubMed ID: 27180559
[TBL] [Abstract][Full Text] [Related]
18. Moyamoya syndrome associated with Down syndrome: outcome after surgical revascularization.
Jea A; Smith ER; Robertson R; Scott RM
Pediatrics; 2005 Nov; 116(5):e694-701. PubMed ID: 16263984
[TBL] [Abstract][Full Text] [Related]
19. Clinical features, surgical treatment and long-term outcome in adult patients with Moyamoya disease in China.
Bao XY; Duan L; Li DS; Yang WZ; Sun WJ; Zhang ZS; Zong R; Han C
Cerebrovasc Dis; 2012; 34(4):305-13. PubMed ID: 23146868
[TBL] [Abstract][Full Text] [Related]
20. Revascularization of Moyamoya Angiopathy in Older Adults.
Williamson RW; Abla AA; Zabramski JM; Nakaji P; Spetzler RF; Wanebo JE
World Neurosurg; 2017 Mar; 99():37-40. PubMed ID: 27890765
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
